Annexon (ANNX) announced the appointment of William “BJ” Jones to its board of directors. He currently serves as chief commercial officer of NewAmsterdam Pharma Company (NAMS).
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANNX:
- Annexon (ANNX) Surges with Promising Phase 3 Results for Guillain-Barré Syndrome Treatment
- Annexon announces topline results from RWE study of ANX005 in GBS
- Annexon to present Phase 2 ARCHER DATA on ANX007
- Annexon Biosciences Reports Q3 Financial Results
- Annexon reports Q3 EPS (25c), consensus (27c)